Luke Evnin sold $43K of HOWL stock

Luke Evnin, Dir of Werewolf Therapeutics, Inc. (HOWL), sold 105,565 shares of HOWL stock worth $43K, per an SEC Form 4 filed Jun 8, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Jun 4, 2026, 4 days before it was made public.

HOWL has moved +127.9% since the trade date, from $0.43 to $0.98 (Nov 12, 2026 close).